APA (7th ed.) Citation

AM, W., E, Z., BK, I., BN, V., S, J., L, N., . . . JD, S. (2026). Effects of disease modifying therapy on cognitive proficiency in pediatric-onset multiple sclerosis (POMS). Multiple sclerosis and related disorders, 109, 107104. https://doi.org/10.1016/j.msard.2026.107104

Chicago Style (17th ed.) Citation

AM, Whitaker, et al. "Effects of Disease Modifying Therapy on Cognitive Proficiency in Pediatric-onset Multiple Sclerosis (POMS)." Multiple Sclerosis and Related Disorders 109 (2026): 107104. https://doi.org/10.1016/j.msard.2026.107104.

MLA (9th ed.) Citation

AM, Whitaker, et al. "Effects of Disease Modifying Therapy on Cognitive Proficiency in Pediatric-onset Multiple Sclerosis (POMS)." Multiple Sclerosis and Related Disorders, vol. 109, 2026, p. 107104, https://doi.org/10.1016/j.msard.2026.107104.